TriMas (NASDAQ:TRS) Downgraded to “Hold” Rating by Wall Street Zen

TriMas (NASDAQ:TRSGet Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.

Other equities research analysts also recently issued research reports about the company. BWS Financial reaffirmed a “buy” rating and set a $45.00 target price on shares of TriMas in a research report on Friday. Weiss Ratings restated a “hold (c+)” rating on shares of TriMas in a report on Monday. Zacks Research raised shares of TriMas from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 29th. Finally, KeyCorp cut their target price on TriMas from $45.00 to $38.00 and set an “overweight” rating on the stock in a research report on Thursday, November 13th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $41.50.

Get Our Latest Research Report on TRS

TriMas Price Performance

TriMas stock opened at $33.48 on Friday. The stock’s 50 day moving average is $35.09 and its 200 day moving average is $33.49. TriMas has a one year low of $19.33 and a one year high of $40.34. The firm has a market cap of $1.36 billion, a P/E ratio of 31.00 and a beta of 0.62. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.42.

TriMas (NASDAQ:TRSGet Free Report) last posted its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.04. TriMas had a return on equity of 12.39% and a net margin of 4.35%.The firm had revenue of $269.26 million during the quarter, compared to analyst estimates of $262.05 million. During the same period last year, the company posted $0.43 EPS. The business’s quarterly revenue was up 17.4% on a year-over-year basis. TriMas has set its FY 2025 guidance at 2.020-2.120 EPS. As a group, research analysts expect that TriMas will post 1.69 EPS for the current year.

Insider Activity

In related news, Director Jeffrey A. Fielkow bought 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 11th. The stock was bought at an average cost of $31.46 per share, for a total transaction of $62,920.00. Following the completion of the transaction, the director owned 17,653 shares of the company’s stock, valued at approximately $555,363.38. The trade was a 12.78% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 14.20% of the company’s stock.

Institutional Investors Weigh In On TriMas

Large investors have recently added to or reduced their stakes in the company. Mariner LLC boosted its holdings in shares of TriMas by 2.2% in the 3rd quarter. Mariner LLC now owns 19,536 shares of the industrial products company’s stock worth $755,000 after purchasing an additional 414 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in shares of TriMas by 8.1% during the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 8,693 shares of the industrial products company’s stock valued at $336,000 after buying an additional 654 shares in the last quarter. BNP Paribas Financial Markets lifted its position in TriMas by 35.4% in the 2nd quarter. BNP Paribas Financial Markets now owns 3,319 shares of the industrial products company’s stock worth $95,000 after buying an additional 868 shares during the last quarter. Quarry LP bought a new stake in TriMas in the 3rd quarter worth approximately $36,000. Finally, AE Wealth Management LLC boosted its stake in TriMas by 13.2% in the third quarter. AE Wealth Management LLC now owns 8,408 shares of the industrial products company’s stock worth $325,000 after buying an additional 982 shares in the last quarter. Hedge funds and other institutional investors own 99.42% of the company’s stock.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Further Reading

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.